Mickey Tseng, MD
Orthopaedic Surgery · Honolulu, HINPI 1073624276
Payments from drug & device makers
What this record shows
19 manufacturers reported payments, led by Zimmer Biomet at 31.0% of the total. Reporting peaked in 2022 at $2,304 and has fallen 59.7% since, to $928 in 2025.
Across 42 payments — averaging $124.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$2K
- Ortho Development Corporation$1K
- Stryker$602
- Orthalign Inc$356
- Heraeus Medical, LLC.$187
- Kowa Pharmaceuticals America, Inc.$180
- plus $1K from 13 others
What the payments were for
- Travel & lodging$2,11640%
- Food & beverage$3,11960%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 7 | $1,625 |
| Ortho Development Corporation | 6 | $1,158 |
| Stryker | 2 | $602 |
| Orthalign Inc | 2 | $356 |
| Heraeus Medical, LLC. | 2 | $187 |
| Kowa Pharmaceuticals America, Inc. | 4 | $180 |
| Amgen | 7 | $171 |
| GRT US Holding, Inc. | 1 | $150 |
| Janssen Scientific Affairs, LLC | 1 | $138 |
| Next Science LLC | 1 | $114 |
| Orthogrid Systems Inc | 1 | $113 |
| Smith+Nephew | 1 | $87 |
| Encore Medical, LP | 1 | $81 |
| Averitas Pharma Inc. | 1 | $66 |
| Collegium Pharmaceutical, Inc. | 1 | $54 |
| Nextstep Arthropedix, LLC | 1 | $52 |
| Sanara Medtech Inc. | 1 | $46 |
| Scilex Pharmaceuticals Inc. | 1 | $34 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA$1,498
- BKS TriMax$871
- ICONIX$584
- Trivicta$512
- ORTHALIGN PLUS$356
- Entrada Hip Stem$205
- Qutenza$150
- BKS Uni$142
- Ovation Tribute Hip Stem$142
- XARELTO$138
- BKS Revision$136
- Pivot Bipolar$136
- Seglentis$125
- Legend$124
- PALACOS$116
- Xperience$114
- BlastX$114
- SurgX$114
How this compares
$5,235 in reported general payments places this provider in the 60th percentile of 83 orthopaedic surgery providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 13 | $1,374 |
| Famotidine | 91 | $1,182 |
| Meloxicam | 136 | $713 |
| Celecoxib | 32 | $707 |
| Tramadol Hcl | 36 | $206 |
| Methylprednisolone | 11 | $139 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Honolulu
- Cass NakasoneHonolulu$957K
- Darin AwayaHonolulu$445K
- Christian KikuchiHonolulu$142K
- Paul MortonHonolulu$83K
- Gary OkamuraHonolulu$69K
- Andrew RichardsonHonolulu$55K
- Kyle MitsunagaHonolulu$52K
- Kanu OkikeHonolulu$47K
- Brian ManninoHonolulu$43K
- Morris MitsunagaHonolulu$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.